Tex. Ins. Code § 1369.001

Current with legislation from the 2023 Regular and Special Sessions signed by the Governor as of November 21, 2023.
Section 1369.001 - Definitions

In this subchapter:

(1) "Contraindication" means the potential for, or the occurrence of:
(A) an undesirable change in the therapeutic effect of a prescribed drug because of the presence of a disease condition in the patient for whom the drug is prescribed; or
(B) a clinically significant adverse effect of a prescribed drug on a disease condition of the patient for whom the drug is prescribed.
(2) "Drug" has the meaning assigned by Section 551.003, Occupations Code.
(2-a) "Enrollee" means an individual who is covered under a health benefit plan, including a covered dependent.
(3) "Indication" means a symptom, cause, or occurrence in a disease that points out the cause, diagnosis, course of treatment, or prognosis of the disease.
(4) "Peer-reviewed medical literature" means scientific studies published in a peer-reviewed national professional journal.

Tex. Ins. Code § 1369.001

Amended by Acts 2017, Texas Acts of the 85th Leg. - Regular Session, ch. 727,Sec. 1, eff. 9/1/2017.
Added by Acts 2003, 78th Leg., ch. 1274, Sec. 3, eff. 4/1/2005.